These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28451822)

  • 21. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
    Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
    Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel glucokinase deletion (p.Lys32del) and five previously described mutations co-segregate with the phenotype of mild familial hyperglycaemia (MODY2) in Brazilian families.
    Giuffrida FM; Calliari LE; Manna TD; Ferreira JG; Saddi-Rosa P; Kunii IS; Furuzawa GK; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2013 May; 100(2):e42-5. PubMed ID: 23433541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
    Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
    Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ancestral mutations may cause a significant proportion of GCK-MODY.
    Dusatkova P; Pruhova S; Borowiec M; Vesela K; Antosik K; Lebl J; Mlynarski W; Cinek O
    Pediatr Diabetes; 2012 Sep; 13(6):489-98. PubMed ID: 22332836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
    Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?
    Timsit J; Saint-Martin C; Dubois-Laforgue D; Bellanné-Chantelot C
    Can J Diabetes; 2016 Oct; 40(5):455-461. PubMed ID: 27103109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype.
    Cappelli A; Tumini S; Consoli A; Carinci S; Piersanti C; Ruggiero G; Simonella G; Soletti F; Staffolani P; Pianese L
    Diabetes Res Clin Pract; 2009 Mar; 83(3):e72-4. PubMed ID: 19150152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MODY type 2 P59S GCK mutant: founder effect in South of Italy.
    Delvecchio M; Ludovico O; Bellacchio E; Stallone R; Palladino T; Mastroianno S; Zelante L; Sacco M; Trischitta V; Carella M
    Clin Genet; 2013 Jan; 83(1):83-7. PubMed ID: 22335469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low prevalence of glucokinase gene mutations in gestational diabetic patients with good glycemic control.
    Frigeri HR; Santos IC; Réa RR; Almeida AC; Fadel-Picheth CM; Pedrosa FO; Souza EM; Rego FG; Picheth G
    Genet Mol Res; 2012 May; 11(2):1433-41. PubMed ID: 22653590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic counseling in monogenic diabetes GCK MODY.
    Skała-Zamorowska E; Deja G; Borowiec M; Fendler W; Małachowska B; Kamińska H; Młynarski W; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):54-59. PubMed ID: 28329773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of dietary carbohydrate content on glycaemia in patients with glucokinase maturity-onset diabetes of the young.
    Klupa T; Solecka I; Nowak N; Szopa M; Kiec-Wilk B; Skupien J; Trybul I; Matejko B; Mlynarski W; Malecki MT
    J Int Med Res; 2011; 39(6):2296-301. PubMed ID: 22289546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new de novo mutation in the GCK gene causing MODY2.
    Cappelli A; Silvestri S; Tumini S; Carinci S; Cipriano P; Massi L; Staffolani P; Pianese L
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e41-3. PubMed ID: 21514682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II).
    Weng J; Zhao J; Zhou Z; Guo X; Zou D; Ji Q; Tong N; Li Q; Zhu J; Li Q; Qin G; Feng P; Yang L; Gao Z; Chen L; Li H; Li Y; Zeng L; Zhu D; Lu J; Luo T; Cui N
    J Diabetes; 2020 Jan; 12(1):66-76. PubMed ID: 31222955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes: Leveraging the Tipping Point of the Diabetes Pandemic.
    Weng JP; Hu G
    Diabetes; 2017 Jun; 66(6):1461-1463. PubMed ID: 28533297
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression.
    Zeng K; Tian L; Sirek A; Shao W; Liu L; Chiang YT; Chernoff J; Ng DS; Weng J; Jin T
    J Mol Cell Biol; 2017 Oct; 9(5):384-394. PubMed ID: 28992163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of type 1 diabetes in China, 2010-13: population based study.
    Weng J; Zhou Z; Guo L; Zhu D; Ji L; Luo X; Mu Y; Jia W;
    BMJ; 2018 Jan; 360():j5295. PubMed ID: 29298776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two Novel MicroRNA Biomarkers Related to β-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes.
    Liu L; Yan J; Xu H; Zhu Y; Liang H; Pan W; Yao B; Han X; Ye J; Weng J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1320-1329. PubMed ID: 29370422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.